Published on 9 May 2022 on Motley Fool
A pharmaceutical company might start by using OptimizeRx's network to promote one drug, and then expand the relationship to more... sooner rather than...
Start tracking your investments with Statfolio
Innate Pharma S.A. Sponsored ADR (IPHA) appears an attractive pick, as it has been recently upgra...
Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript March 21, 2024 Innate Pharma S....
Innate Pharma SA IPHA announced that the FDA lifted the partial clinical hold placed on the lacut...
In this article, we discuss the 15 undervalued defensive stocks for 2024. To skip the detailed ov...
Any investor seeking growth stocks that are poised to triple in 2023 will need a strong appetite ...
By the beginning of November this year, ORIC stock had fallen in value to >$2.5 - a market cap...
Sanofi SNY and partner Regeneron REGN announced that the Committee for Medicinal Products for Hum...
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's...
Shares of Innate Pharma SA ADR rallied about 35% in premarket trading on Monday after the company...
Innate Pharma SA (NASDAQ: IPHA) and Sanofi SA (NASDAQ: SNY) have expanded their collaboration, wi...